Roger G. Harrison
Keine laufenden Positionen mehr
Profil
Roger G.
Harrison served as President & Chief Executive Officer at Antares Pharma, Inc. from 2001 to 2004.
He was also Chairman & President at Performance Health Technologies, Inc. and Chairman at Advanced Respiratory Technologies, Inc. In addition, he worked as a Director at Inyx, Inc. from 2006 to 2007 and as a Medicinal Research Scientist at Eli Lilly & Co. He also served as a Senior Advisor at Arsenal Capital Management LP.
Harrison earned a doctorate degree from the University of Leeds in 1971.
Ehemalige bekannte Positionen von Roger G. Harrison
Unternehmen | Position | Ende |
---|---|---|
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Private Equity Investor | 31.03.2011 |
INYX, INC. | Direktor/Vorstandsmitglied | 01.07.2007 |
ANTARES PHARMA, INC. | Präsident | 01.09.2004 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Advanced Respiratory Technologies, Inc.
Advanced Respiratory Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Respiratory Technologies, Inc. develops medical devices for the treatment of chronic respiratory diseases. The company is based in Land O Lakes, FL. The company was founded by Steven Kessler, Darren A. Rubin. | Vorsitzender | - |
Ausbildung von Roger G. Harrison
University of Leeds | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
INYX, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Performance Health Technologies, Inc.
Performance Health Technologies, Inc. Medical SpecialtiesHealth Technology Performance Health Technologies, Inc. develops and markets performance evaluation and rehabilitation products that monitor and guide exercise and give real-time motivational feedback. The company's products provide varied exercise modes and assessment tools. Its clinical products allow clinicians to print reports for record keeping and compliance. Performance Health Technologies was founded in 1998 and is headquartered in Trenton, NJ. | Health Technology |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Finance |
Advanced Respiratory Technologies, Inc.
Advanced Respiratory Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Respiratory Technologies, Inc. develops medical devices for the treatment of chronic respiratory diseases. The company is based in Land O Lakes, FL. The company was founded by Steven Kessler, Darren A. Rubin. | Health Technology |